Green-synthesized cyclophosphamide-loaded magnetite nanocomposites for in vitro anti-cancer activity against U-87 glioblastoma cells
Glioblastoma multiforme is one of the most aggressive and treatment-resistant brain tumors, necessitating the development of novel drug delivery systems to enhance therapeutic efficacy. This study focuses on the green synthesis, characterization, and anti-cancer potential of cyclophosphamide-loaded...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Results in Chemistry |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211715625004965 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849243409972199424 |
|---|---|
| author | Ayesha Bibi Ayesha Azmat Salman Zafar |
| author_facet | Ayesha Bibi Ayesha Azmat Salman Zafar |
| author_sort | Ayesha Bibi |
| collection | DOAJ |
| description | Glioblastoma multiforme is one of the most aggressive and treatment-resistant brain tumors, necessitating the development of novel drug delivery systems to enhance therapeutic efficacy. This study focuses on the green synthesis, characterization, and anti-cancer potential of cyclophosphamide-loaded magnetite nanoparticles for targeted glioblastoma therapy. Magnetite nanoparticles were synthesized, using Vitis vinifera (raisin) extract via a green precipitation method, and subsequently loaded with cyclophosphamide. The resulting nanocomposite was characterized using advanced spectroscopic and microscopic techniques. Drug loading, encapsulation efficiency, and release kinetics were evaluated, under physiological (pH 7.4) and acidic (pH 5.5) conditions. The genotoxic effects were assessed using the comet assay, while anti-cancer efficacy, against U-87 glioblastoma cells, was determined via the crystal violet assay. The nanocomposite exhibited a 15.8% drug loading capacity and an encapsulation efficiency of 79.4%, with a controlled biphasic drug release pattern, demonstrating enhanced release in acidic conditions (87.4% at pH 5.5 vs. 61.8% at pH 7.4). The negative surface charge (−13.05 mV) confirmed its stability and biocompatibility. Genotoxicity studies indicated dose-dependent DNA damage, validating its mechanism of action. The drug-loaded nanocomposite showed a significantly lower IC₅₀ (422 μM) as compared to the free drug (5272 μM), demonstrating enhanced cytotoxicity against U-87 cells. The nanocomposite thus, exhibits improved bioavailability, controlled drug release, and enhanced anti-cancer efficacy, making it a promising candidate for glioblastoma therapy. Further in vivo studies are warranted to evaluate its clinical potential. |
| format | Article |
| id | doaj-art-93e9897c1d634d2b8380e95184c2a9c8 |
| institution | Kabale University |
| issn | 2211-7156 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Results in Chemistry |
| spelling | doaj-art-93e9897c1d634d2b8380e95184c2a9c82025-08-20T03:59:30ZengElsevierResults in Chemistry2211-71562025-07-011610251310.1016/j.rechem.2025.102513Green-synthesized cyclophosphamide-loaded magnetite nanocomposites for in vitro anti-cancer activity against U-87 glioblastoma cellsAyesha Bibi0Ayesha Azmat1Salman Zafar2Institute of Chemical Sciences, University of Peshawar, Peshawar 25120, PakistanInstitute of Chemical Sciences, University of Peshawar, Peshawar 25120, PakistanCorresponding author.; Institute of Chemical Sciences, University of Peshawar, Peshawar 25120, PakistanGlioblastoma multiforme is one of the most aggressive and treatment-resistant brain tumors, necessitating the development of novel drug delivery systems to enhance therapeutic efficacy. This study focuses on the green synthesis, characterization, and anti-cancer potential of cyclophosphamide-loaded magnetite nanoparticles for targeted glioblastoma therapy. Magnetite nanoparticles were synthesized, using Vitis vinifera (raisin) extract via a green precipitation method, and subsequently loaded with cyclophosphamide. The resulting nanocomposite was characterized using advanced spectroscopic and microscopic techniques. Drug loading, encapsulation efficiency, and release kinetics were evaluated, under physiological (pH 7.4) and acidic (pH 5.5) conditions. The genotoxic effects were assessed using the comet assay, while anti-cancer efficacy, against U-87 glioblastoma cells, was determined via the crystal violet assay. The nanocomposite exhibited a 15.8% drug loading capacity and an encapsulation efficiency of 79.4%, with a controlled biphasic drug release pattern, demonstrating enhanced release in acidic conditions (87.4% at pH 5.5 vs. 61.8% at pH 7.4). The negative surface charge (−13.05 mV) confirmed its stability and biocompatibility. Genotoxicity studies indicated dose-dependent DNA damage, validating its mechanism of action. The drug-loaded nanocomposite showed a significantly lower IC₅₀ (422 μM) as compared to the free drug (5272 μM), demonstrating enhanced cytotoxicity against U-87 cells. The nanocomposite thus, exhibits improved bioavailability, controlled drug release, and enhanced anti-cancer efficacy, making it a promising candidate for glioblastoma therapy. Further in vivo studies are warranted to evaluate its clinical potential.http://www.sciencedirect.com/science/article/pii/S2211715625004965Cyclophosphamide-loaded magnetite nanoparticlesAnti-cancer therapyDrug release profileGenotoxicity assessmentGlioblastoma U-87 cell line |
| spellingShingle | Ayesha Bibi Ayesha Azmat Salman Zafar Green-synthesized cyclophosphamide-loaded magnetite nanocomposites for in vitro anti-cancer activity against U-87 glioblastoma cells Results in Chemistry Cyclophosphamide-loaded magnetite nanoparticles Anti-cancer therapy Drug release profile Genotoxicity assessment Glioblastoma U-87 cell line |
| title | Green-synthesized cyclophosphamide-loaded magnetite nanocomposites for in vitro anti-cancer activity against U-87 glioblastoma cells |
| title_full | Green-synthesized cyclophosphamide-loaded magnetite nanocomposites for in vitro anti-cancer activity against U-87 glioblastoma cells |
| title_fullStr | Green-synthesized cyclophosphamide-loaded magnetite nanocomposites for in vitro anti-cancer activity against U-87 glioblastoma cells |
| title_full_unstemmed | Green-synthesized cyclophosphamide-loaded magnetite nanocomposites for in vitro anti-cancer activity against U-87 glioblastoma cells |
| title_short | Green-synthesized cyclophosphamide-loaded magnetite nanocomposites for in vitro anti-cancer activity against U-87 glioblastoma cells |
| title_sort | green synthesized cyclophosphamide loaded magnetite nanocomposites for in vitro anti cancer activity against u 87 glioblastoma cells |
| topic | Cyclophosphamide-loaded magnetite nanoparticles Anti-cancer therapy Drug release profile Genotoxicity assessment Glioblastoma U-87 cell line |
| url | http://www.sciencedirect.com/science/article/pii/S2211715625004965 |
| work_keys_str_mv | AT ayeshabibi greensynthesizedcyclophosphamideloadedmagnetitenanocompositesforinvitroanticanceractivityagainstu87glioblastomacells AT ayeshaazmat greensynthesizedcyclophosphamideloadedmagnetitenanocompositesforinvitroanticanceractivityagainstu87glioblastomacells AT salmanzafar greensynthesizedcyclophosphamideloadedmagnetitenanocompositesforinvitroanticanceractivityagainstu87glioblastomacells |